Nwam LLC acquired a new position in Grail, Inc. (NASDAQ:GRAL - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm acquired 10,908 shares of the company's stock, valued at approximately $195,000.
A number of other institutional investors have also modified their holdings of GRAL. FNY Investment Advisers LLC purchased a new stake in shares of Grail during the 4th quarter valued at about $26,000. New York State Common Retirement Fund acquired a new position in Grail in the 4th quarter worth $59,000. Wilmington Savings Fund Society FSB purchased a new position in Grail in the 4th quarter valued at about $64,000. Manchester Capital Management LLC acquired a new stake in shares of Grail during the fourth quarter valued at about $123,000. Finally, China Universal Asset Management Co. Ltd. purchased a new stake in shares of Grail during the fourth quarter worth about $127,000.
Grail Stock Down 6.3 %
GRAL stock traded down $2.40 during trading on Thursday, hitting $35.90. 726,742 shares of the company's stock traded hands, compared to its average volume of 1,201,937. Grail, Inc. has a 52 week low of $12.33 and a 52 week high of $63.99. The stock has a fifty day moving average price of $30.09 and a two-hundred day moving average price of $20.61.
Grail (NASDAQ:GRAL - Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, topping analysts' consensus estimates of ($4.41) by $2.55. The company had revenue of $38.25 million for the quarter, compared to analyst estimates of $35.33 million. Research analysts predict that Grail, Inc. will post -15.15 EPS for the current year.
Analyst Ratings Changes
A number of equities analysts have issued reports on GRAL shares. Wolfe Research started coverage on Grail in a research report on Friday, November 15th. They issued a "peer perform" rating on the stock. Morgan Stanley started coverage on Grail in a research note on Wednesday, November 27th. They issued an "equal weight" rating and a $16.00 price target for the company.
Check Out Our Latest Stock Analysis on Grail
About Grail
(
Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Recommended Stories
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
